SUV39H1 and acute myeloid leukemia: The expression of SUV39H1 was reported to decline with age in human and mouse HSCs, thus leading to a global H3K9me3 reduction and perturbed the heterochromatin function [16], and HSC aging increases the likelihood of progression to AML [17].